Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Retrospective, Study on Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer

NCT06877416 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06877416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Retrospective, Study on Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
Lead sponsor
Sun Yat-sen University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2020
Completion date
January 31, 2026
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody-drug conjugates, breast neoplasms, her2-low breast cancer